NCT06359379 2025-12-18Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT PromoterShuttle Pharmaceuticals, Inc.Phase 2 Terminated30 enrolled
NCT04406857 2025-02-26Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal CancerNational Cancer Institute (NCI)Phase 1 Terminated1 enrolled 7 charts